APA ציטוט

Fedirko, V., McKeown-Eyssen, G., Serhan, C. N., Barry, E. L., Sandler, R. S., Figueiredo, J. C., . . . Baron, J. A. (2017). Plasma Lipoxin A(4) and Resolvin D1 are Not Associated with Reduced Adenoma Risk in a Randomized Trial of Aspirin to Prevent Colon Adenomas. Mol Carcinog.

Citação norma Chicago

Fedirko, Veronika, et al. "Plasma Lipoxin A(4) and Resolvin D1 Are Not Associated With Reduced Adenoma Risk in a Randomized Trial of Aspirin to Prevent Colon Adenomas." Mol Carcinog 2017.

ציטוט MLA

Fedirko, Veronika, et al. "Plasma Lipoxin A(4) and Resolvin D1 Are Not Associated With Reduced Adenoma Risk in a Randomized Trial of Aspirin to Prevent Colon Adenomas." Mol Carcinog 2017.